• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Use of point of care molecular tests reduces hospitalization and oseltamivir administration in children presenting with influenza lik

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Sep 23.
doi: 10.1002/jmv.26538. Online ahead of print.
Use of point of care molecular tests reduces hospitalization and oseltamivir administration in children presenting with influenza like illness


Dimitra Dimopoulou[SUP] 1 [/SUP], Sophia Vourli[SUP] 2 [/SUP], Konstantinos Douros[SUP] 1 [/SUP], Spyridon Pournaras[SUP] 2 [/SUP], Vassiliki Papaevangelou[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: Influenza is associated with increased morbidity, health care costs, hospitalization rates and mortality in children. Rapid immuno-chromatography assay (ICA), a test with low sensitivity, is often used as point of care (POC) test. Recently, the rapid syndromic molecular test FilmArray, became available. This observational study aims to evaluate whether the use of FilmArray would decrease the use of antivirals and hospitalization rates among children presenting to the emergency room (ER) with influenza-like-illness (ILI) symptoms.
Materials and methods: Nasopharyngeal swabs were prospectively collected from children 0-16 years presenting with ILI at the ER of a tertiary hospital during the peak endemic period. Patients were allocated to be tested by either FilmArray or ICA. Use of antivirals and hospitalization rates were noted. Logistic regression models were used to investigate the impact of testing methods on decision making.
Results: Overall, 80 children were included (mean age: 5 years). Admissions were more likely to occur if ICA test was performed (OR:3.16, 95%CI: 1.01-9.82, p=0.046). Oseltamivir administration was more likely among children who had undergone the ICA test (OR: 4.67, 95%CI: 1.06-20.43, p=0.041). The implementation of rapid molecular test had no impact on complementary diagnostic testing or antibacterial prescription.
Conclusions: The use of FilmArray significantly reduced both hospitalization and oseltamivir administration in children. Further education on the use of POC tests is needed to improve current management of children presenting with ILI and decrease associated health care costs. This article is protected by copyright. All rights reserved.

Keywords: Influenza virus; antiviral agents; seasonal incidence.
 
Back
Top Bottom